On May 30, 2019 Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune and viral diseases, reported that Utpal Koppikar, the Company’s Chief Financial Officer, will participate at two upcoming investor conferences in June (Press release, Atara Biotherapeutics, MAY 30, 2019, View Source [SID1234536686]):
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Jefferies 2019 Global Healthcare Conference
Company Presentation: Wednesday, June 5, 2019 at 8:30 a.m. EDT
Grand Hyatt in New York, NY
Goldman Sachs 40th Annual Global Healthcare Conference
Fireside Chat: Thursday, June 13, 2019 at 10:00 a.m. PDT
Terranea Resort in Rancho Palos Verdes, CA
Live audio webcasts of the presentation and fireside chat will be available by visiting the Investor Events and Presentations section of atarabio.com. Archived replays will be available on the Company’s website for approximately 14 days following the live webcasts.